Home
Latest
E-paper
Companies
Industry
Economy
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Indulgence
Premium
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
US books 100 mn Covid-19 vaccine doses for $2.1 bn from GSK, Sanofi Pasteur
The US government has a further option for the supply of an additional 500 million doses longer term as part of its Operation Warp Speed programme
Sanofi, US govt join hands to expedite development of coronavirus vaccine
Sanofi plans to further investigate an advanced pre-clinical SARS vaccine candidate that could protect against COVID-19
Sanofi Pasteur readies pipeline of 11 vaccines for RSV, hepatitis A, herpes
Sanofi had acquired Shantha Biotechnics in 2009, which makes vaccines for the company in India
